{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:56:36Z","timestamp":1783083396491,"version":"3.54.6"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clp.2010.08.012","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T09:16:53Z","timestamp":1289726213000},"page":"887-905","source":"Crossref","is-referenced-by-count":11,"title":["Issues of Prematurity and HIV Infection"],"prefix":"10.1016","volume":"37","author":[{"given":"Julie","family":"Mirpuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucky","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2010.08.012_bib1","first-page":"592","article-title":"Reduction in perinatal transmission of HIV infection\u2014United States, 1985\u20132005","volume":"55","author":"Achievements in public health","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0020-7292(95)02356-H","article-title":"Impact of maternal HIV-1 infection on perinatal outcome","volume":"49","author":"Kumar","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clp.2010.08.012_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00002030-199806000-00014","article-title":"Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992\u20131994. Pregnancy and HIV Study Group","volume":"12","author":"Leroy","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00006250-199404000-00002","article-title":"Maternal human immunodeficiency virus-1 infection and pregnancy outcome","volume":"83","author":"Temmerman","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pcl.2009.03.009","article-title":"Health issues of the late preterm infant","volume":"56","author":"Ramachandrappa","year":"2009","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"10.1016\/j.clp.2010.08.012_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/jpm.2010.052","article-title":"Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003\u20132008","volume":"38","author":"Aebi-Popp","year":"2010","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.clp.2010.08.012_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.282.6.531","article-title":"Trends in perinatal transmission of HIV\/AIDS in the United States","volume":"282","author":"Lindegren","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2010.08.012_bib8","unstructured":"Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2007. Available at: http:\/\/www.cdc.gov\/hiv\/surveillance\/resources\/reports\/2007report\/. Accessed August 18, 2010."},{"key":"10.1016\/j.clp.2010.08.012_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00126334-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clp.2010.08.012_bib10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2010.08.012_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clp.2010.08.012_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1447-0756.2008.00925.x","article-title":"Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV","volume":"35","author":"Traisathit","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.clp.2010.08.012_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jech.53.10.624","article-title":"Socioeconomic and work related determinants of pregnancy outcome in southern Thailand","volume":"53","author":"Tuntiseranee","year":"1999","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.clp.2010.08.012_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-3476(97)70032-5","article-title":"Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group","volume":"131","author":"Martin","year":"1997","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2010.08.012_bib15","first-page":"189","article-title":"Racial\/ethnic disparities in diagnoses of HIV\/AIDS\u201433 states, 2001\u20132005","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib16","first-page":"589","article-title":"Epidemiology of HIV\/AIDS\u2014United States, 1981\u20132005","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.283.9.1175","article-title":"Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice","volume":"283","author":"De Cock","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2010.08.012_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/596477","article-title":"Pregnancy and optimal care of HIV-infected patients","volume":"48","author":"Anderson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2010.08.012_bib19","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0029-7844(03)00624-0","article-title":"Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission","volume":"102","author":"Sansom","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/14740330903241584","article-title":"A\u00a0review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV","volume":"8","author":"Nurutdinova","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clp.2010.08.012_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy","volume":"127","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clp.2010.08.012_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/0003-4819-127-10-199711150-00017","article-title":"New-onset diabetes mellitus associated with use of protease inhibitor","volume":"127","author":"Eastone","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clp.2010.08.012_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.jp.7210748","article-title":"Protease inhibitors and decreased birth weight in HIV-infected pregnant women with impaired glucose tolerance","volume":"22","author":"Chmait","year":"2002","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2010.08.012_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/S1064744902000212","article-title":"Lack of an effect of protease inhibitor use on glucose tolerance during pregnancy","volume":"10","author":"Dinsmoor","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.AOG.0000207657.94360.78","article-title":"Effect of protease inhibitor therapy on glucose intolerance in pregnancy","volume":"107","author":"Tang","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib28","unstructured":"Recommendations for use of antiretroviral drugs in pregnant HIV-1-Infected women for maternal health and Interventions to reduce perinatal HIV transmission in the United States. 2010. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL.pdf. Accessed August 18, 2010."},{"key":"10.1016\/j.clp.2010.08.012_bib29","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2010.08.012_bib30","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"Combination antiretroviral therapy and duration of pregnancy","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib31","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2010.08.012_bib32","doi-asserted-by":"crossref","unstructured":"Patel K, Shapiro DE, Brogly SB, et\u00a0al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis 2010;201:1035\u201344.","DOI":"10.1086\/651232"},{"key":"10.1016\/j.clp.2010.08.012_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/JPM.2005.053","article-title":"The epidemiology of preterm labor\u2014a global perspective","volume":"33","author":"Steer","year":"2005","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.clp.2010.08.012_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(05)71042-4","article-title":"The challenge of reducing neonatal mortality in middle-income countries: findings from three Brazilian birth cohorts in 1982, 1993, and 2004","volume":"365","author":"Barros","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2010.08.012_bib36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort","volume":"17","author":"Barret","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-3542(03)00069-X","article-title":"Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions","volume":"58","author":"Lewis","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.clp.2010.08.012_bib38","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2010.08.012_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-200404300-00009","article-title":"Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir","volume":"18","author":"Divi","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/em.20201","article-title":"Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"48","author":"Divi","year":"2007","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.clp.2010.08.012_bib41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2010.08.012_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00126334-200306010-00010","article-title":"Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers","volume":"33","author":"Poirier","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clp.2010.08.012_bib44","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/00002030-200309260-00006","article-title":"Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants","volume":"17","author":"Le Chenadec","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/08035250510042951","article-title":"Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers","volume":"94","author":"Bunders","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clp.2010.08.012_bib46","doi-asserted-by":"crossref","unstructured":"Joao EC, Calvet GA, Krauss MR, et\u00a0al. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. J Acquir Immune Defic Syndr 2010;53:176\u201385.","DOI":"10.1097\/QAI.0b013e3181c5c81f"},{"key":"10.1016\/j.clp.2010.08.012_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"Garcia","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2010.08.012_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/318530","article-title":"Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies\/ml","volume":"183","author":"Ioannidis","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2010.08.012_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0020-7292(01)00412-X","article-title":"ACOG committee opinion scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999)","volume":"73","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clp.2010.08.012_bib50","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"European Collaborative Study Group. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2010.08.012_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200102160-00009","article-title":"International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies","volume":"15","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.clp.2010.08.012_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0020-7292(03)00123-1","article-title":"Duration of ruptured membranes and extended labor are risk factors for HIV transmission","volume":"82","author":"Garcia-Tejedor","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2010.08.012_bib53","first-page":"24A","article-title":"Epidemiology of herpes simplex virus type 2 infection in the developing world","volume":"11","author":"Weiss","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.clp.2010.08.012_bib54","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1086\/383049","article-title":"Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial","volume":"189","author":"Baeten","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2010.08.012_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00126334-200306010-00001","article-title":"Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women","volume":"33","author":"Mbopi-Keou","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clp.2010.08.012_bib56","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/517297","article-title":"The impact of active herpes simplex virus infection on human immunodeficiency virus load","volume":"176","author":"Mole","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2010.08.012_bib57","doi-asserted-by":"crossref","unstructured":"Lingappa JR, Baeten JM, Wald A, et\u00a0al. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010;375:824\u201333.","DOI":"10.1016\/S0140-6736(09)62038-9"},{"key":"10.1016\/j.clp.2010.08.012_bib58","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.AOG.0000185917.90004.7c","article-title":"Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus","volume":"106","author":"Chen","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib59","doi-asserted-by":"crossref","unstructured":"Lunney KM, Iliff P, Mutasa K, et\u00a0al. Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin Infect Dis 2010;50:762\u20139.","DOI":"10.1086\/650535"},{"key":"10.1016\/j.clp.2010.08.012_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1542\/peds.114.2.497","article-title":"Evaluation and treatment of the human immunodeficiency virus-1\u2013exposed infant","volume":"114","author":"King","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2010.08.012_bib61","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1136\/fn.88.1.F11","article-title":"Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review","volume":"88","author":"McGuire","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5 Pt 1","key":"10.1016\/j.clp.2010.08.012_bib62","first-page":"1119","article-title":"Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations","volume":"104","author":"ACOG committee opinion number 304, November 2004","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2010.08.012_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jama.292.2.219","article-title":"Rapid HIV-1 testing during labor: a multicenter study","volume":"292","author":"Bulterys","year":"2004","journal-title":"JAMA"},{"issue":"3 Pt 1","key":"10.1016\/j.clp.2010.08.012_bib64","first-page":"481","article-title":"virus infection. American Academy of Pediatrics. Committee on Infectious Diseases","volume":"101","author":"Hepatitis","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2010.08.012_bib65","doi-asserted-by":"crossref","DOI":"10.1542\/peds.106.6.e88","article-title":"Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Committee on Pediatric Aids","volume":"106","author":"Mofenson","year":"2000","journal-title":"Pediatrics"},{"issue":"RR-18","key":"10.1016\/j.clp.2010.08.012_bib66","first-page":"1","article-title":"U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States","volume":"51","author":"Mofenson","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/AAC.39.1.125","article-title":"Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS","volume":"39","author":"Van Rompay","year":"1995","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.clp.2010.08.012_bib68","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.270.5239.1197","article-title":"Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine","volume":"270","author":"Tsai","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clp.2010.08.012_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002030-199702000-00004","article-title":"Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005","volume":"11","author":"Bottiger","year":"1997","journal-title":"AIDS"},{"issue":"RR-10","key":"10.1016\/j.clp.2010.08.012_bib70","first-page":"1","article-title":"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years\u2014United States, 2008","volume":"57","author":"Schneider","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.clp.2010.08.012_bib71","first-page":"31","article-title":"Recommended childhood immunization schedule\u2014United States, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5 Pt 1","key":"10.1016\/j.clp.2010.08.012_bib72","first-page":"1057","article-title":"Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS","volume":"103","year":"1999","journal-title":"Pediatrics"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510810001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510810001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T08:27:03Z","timestamp":1559809623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510810001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0095510810001053"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2010.08.012","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}